Attana AB announced that at its AGM held on May 7, 2021, Per Aniansson was elected new Board member. During the period 2011-2019, he was responsible for medical technology investments at Fouriertransform and served on the board of the Life Science companies OssDsign and Scibase. Per is currently Investment Director and CFO at the investment firm Karolinska Development, investing in Nordic growth stage companies within the Life Science sector.